State laws and prescribing rates of generic drugs in dermatology: a cross-sectional analysis of 2020 Medicare Part D claims data

Arch Dermatol Res. 2023 Dec;315(10):2991-2993. doi: 10.1007/s00403-023-02719-x. Epub 2023 Sep 15.

Authors

Michael Joseph Diaz¹, Jasmine Thuy Tran², Mahtab Forouzandeh³

Affiliations

¹ College of Medicine, University of Florida, Gainesville, FL, USA. michaeldiaz@ufl.edu.
² School of Medicine, Indiana University, Indianapolis, IN, USA.
³ Department of Dermatology, University of Florida, Gainesville, FL, USA.

PMID: 37712969
DOI: 10.1007/s00403-023-02719-x

No abstract available

Keywords: Generic drugs; Medical dermatology; Medicare Part D; Prescribing rate.

Publication types

Letter

MeSH terms

Aged
Cross-Sectional Studies
Dermatology*
Drugs, Generic / therapeutic use
Humans
Medicare Part D*
Prescription Drugs*
United States

Substances

Drugs, Generic
Prescription Drugs